A proposed false advertising class action over two joint health supplements should be dismissed because the plaintiff failed to support her argument that the advertising was legally problematic, the defendants argued in court papers.
Putative class representative Georgia Ferrell argues that, under California law, Cosamin DS and Cosamin ASU were falsely advertised because the glucosamine and chondroitin sulfate in them “are worthless and ineffective.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
